Toronto Dominion Bank
IGC icon

Toronto Dominion Bank’s IGC Pharma IGC Stock Holding History

Toronto Dominion Bank’s Portfolio IGC Stock Details IGC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-6
Closed -$3 – 1289
2024
Q2 		$3 Hold
6
– – ﹤0.01% 1433
2024
Q1 		$2 Hold
6
– – ﹤0.01% 1410
2023
Q4 		$2 Hold
6
– – ﹤0.01% 1570
2023
Q3 		$2 Hold
6
– – ﹤0.01% 1821
2023
Q2 		$0 Hold
6
– – ﹤0.01% 1632
2023
Q1 		$0 Buy
+6
New +$2 ﹤0.01% 1573
2022
Q3 		– Sell
-1,106
Closed -$1K – 1632
2022
Q2 		$1K Hold
1,106
– – ﹤0.01% 1250
2022
Q1 		$1K Sell
1,106
-2
-0.2% -$2 ﹤0.01% 1335
2021
Q4 		$1K Buy
1,108
+898
+428% +$1.21K ﹤0.01% 1456
2021
Q3 		$0 Buy
+210
New +$340 ﹤0.01% 1419

Other funds holding IGC

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
DP
Dearborn Partners Chicago, Illinois $1.85B AUM 6.59% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
FW
FullCircle Wealth Dallas, Texas $284M AUM 15.13% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Toronto Dominion Bank's IGC Position: Q3 2024 in Review

Toronto Dominion Bank sold out of IGC Pharma (IGC) in Q3 2024, closing a stake of 6 shares — an estimated $3 sold.

Toronto Dominion Bank first reported a position in IGC in Q3 2021 and held it in 10 quarters. The position peaked at $1K in Q2 2022. 23 funds tracked by Wall St. Rank hold IGC as of Q3 2024.

  • Toronto Dominion Bank reported no remaining IGC Pharma position as of Q3 2024 after selling out during the quarter.
  • Toronto Dominion Bank sold 6 IGC Pharma shares in Q3 2024, an estimated $3.
  • Toronto Dominion Bank first reported a position in IGC Pharma in Q3 2021 and held it in 10 quarters.
  • Toronto Dominion Bank's IGC Pharma position peaked at $1K in Q2 2022.
  • 23 funds tracked by Wall St. Rank held IGC Pharma as of Q3 2024.

Based on Toronto Dominion Bank's 13F filing for Q3 2024, filed 14 Nov 2024.